These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15586220)

  • 1. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.
    Carl-McGrath S; Lendeckel U; Ebert M; Roessner A; Röcken C
    Int J Oncol; 2005 Jan; 26(1):17-24. PubMed ID: 15586220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling.
    Le Pabic H; Bonnier D; Wewer UM; Coutand A; Musso O; Baffet G; Clément B; Théret N
    Hepatology; 2003 May; 37(5):1056-66. PubMed ID: 12717386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines.
    Lendeckel U; Kohl J; Arndt M; Carl-McGrath S; Donat H; Röcken C
    J Cancer Res Clin Oncol; 2005 Jan; 131(1):41-8. PubMed ID: 15565459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.
    Uehara E; Shiiba M; Shinozuka K; Saito K; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Tanzawa H
    Int J Oncol; 2012 May; 40(5):1414-22. PubMed ID: 22267082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulated expression of ADAM17 in gastrointestinal stromal tumors: coexpression with EGFR and EGFR ligands.
    Nakagawa M; Nabeshima K; Asano S; Hamasaki M; Uesugi N; Tani H; Yamashita Y; Iwasaki H
    Cancer Sci; 2009 Apr; 100(4):654-62. PubMed ID: 19298600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression.
    Kim JM; Jeung HC; Rha SY; Yu EJ; Kim TS; Shin YK; Zhang X; Park KH; Park SW; Chung HC; Powis G
    Mol Cancer Ther; 2014 Dec; 13(12):3074-85. PubMed ID: 25344581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria.
    Arndt M; Lendeckel U; Röcken C; Nepple K; Wolke C; Spiess A; Huth C; Ansorge S; Klein HU; Goette A
    Circulation; 2002 Feb; 105(6):720-5. PubMed ID: 11839628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins.
    Mahimkar RM; Visaya O; Pollock AS; Lovett DH
    Biochem J; 2005 Jan; 385(Pt 2):461-8. PubMed ID: 15361064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126.
    Wang J; Zhou Y; Fei X; Chen X; Yan J; Liu B; Zhu Z
    Oncol Rep; 2017 Apr; 37(4):2033-2040. PubMed ID: 28260063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis.
    Shintani Y; Higashiyama S; Ohta M; Hirabayashi H; Yamamoto S; Yoshimasu T; Matsuda H; Matsuura N
    Cancer Res; 2004 Jun; 64(12):4190-6. PubMed ID: 15205330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells.
    Kang Q; Cao Y; Zolkiewska A
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):883-92. PubMed ID: 11104699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated expression of ADAM9 in anterior polar cataracts.
    Lim JM; Lee JH; Wee WR; Joo CK
    J Cataract Refract Surg; 2002 Apr; 28(4):697-702. PubMed ID: 11955914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain.
    Zolkiewska A
    Exp Cell Res; 1999 Nov; 252(2):423-31. PubMed ID: 10527632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells.
    Micocci KC; Moritz MN; Lino RL; Fernandes LR; Lima AG; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
    Biochimie; 2016; 128-129():174-82. PubMed ID: 27554339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM15 overexpression in NIH3T3 cells enhances cell-cell interactions.
    Herren B; Garton KJ; Coats S; Bowen-Pope DF; Ross R; Raines EW
    Exp Cell Res; 2001 Nov; 271(1):152-60. PubMed ID: 11697891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins alpha5beta1 and alphavbeta3 in atherosclerosis.
    Al-Fakhri N; Wilhelm J; Hahn M; Heidt M; Hehrlein FW; Endisch AM; Hupp T; Cherian SM; Bobryshev YV; Lord RS; Katz N
    J Cell Biochem; 2003 Jul; 89(4):808-23. PubMed ID: 12858346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma.
    Mino N; Miyahara R; Nakayama E; Takahashi T; Takahashi A; Iwakiri S; Sonobe M; Okubo K; Hirata T; Sehara A; Date H
    J Surg Oncol; 2009 Sep; 100(3):267-72. PubMed ID: 19544357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adam-9 expression and regulation in human skin melanoma and melanoma cell lines.
    Zigrino P; Mauch C; Fox JW; Nischt R
    Int J Cancer; 2005 Oct; 116(6):853-9. PubMed ID: 15856464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells.
    Tanida S; Joh T; Itoh K; Kataoka H; Sasaki M; Ohara H; Nakazawa T; Nomura T; Kinugasa Y; Ohmoto H; Ishiguro H; Yoshino K; Higashiyama S; Itoh M
    Gastroenterology; 2004 Aug; 127(2):559-69. PubMed ID: 15300588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways.
    Li W; Wang D; Sun X; Zhang Y; Wang L; Suo J
    Int J Mol Med; 2019 Feb; 43(2):914-926. PubMed ID: 30569104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.